Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

On Respiratory Impairment in Cancer Cells

Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472 · see citing works

A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · see citing works

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · see citing works

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · see citing works

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,633 · see citing works

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528 · see citing works

ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis

Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444 · see citing works

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I

El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · see citing works

Melanoma biology and new targeted therapy

Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371 · see citing works

The Concept of Synthetic Lethality in the Context of Anticancer Therapy

Kaelin, W. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1691 · Cited by 1,369 · see citing works

Targeting lactate metabolism for cancer therapeutics

Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,173 · see citing works

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis

Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105 · see citing works

Metformin: An Update

Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · see citing works

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048 · see citing works

Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells

Spinazzi, M., Casarin, A., Pertegato, V., Salviati, L., & Angelini, C. I. (2012) · Nature Protocols · doi:10.1038/nprot.2012.058 · Cited by 989 · see citing works

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918 · see citing works

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861 · see citing works

Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia

Xu, R., Pelicano, H., Zhou, Y. N., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., & Huang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.613.65.2 · Cited by 835 · see citing works

Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF

Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C., Frederick, D. T., Hurley, A. D., Nellore, A., Kung, A. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.003 · Cited by 818 · see citing works

Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis

Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816 · see citing works

Mitochondrial mutations in cancer

Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 815 · see citing works

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 657 · see citing works

Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis

Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536 · see citing works

Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning

Pollak, M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 505 · see citing works

Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression

Santidrián, A. F., Matsuno‐Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding‐Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 435 · see citing works

Lactate: mirror and motor of tumor malignancy

Walenta, S., & Mueller‐Klieser, W. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.004 · Cited by 432 · see citing works

Metformin directly acts on mitochondria to alter cellular bioenergetics

Andrzejewski, S., Gravel, S., Pollak, M., & St‐Pierre, J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-12 · Cited by 424 · see citing works

Tumor metabolism: cancer cells give and take lactate

Semenza, G. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37373 · Cited by 351 · see citing works

Life and death decisions by the E2F transcription factors

Iaquinta, P. J., & Lees, J. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.006 · Cited by 304 · see citing works

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms

Tomić, T., Botton, T., Cerezo, M., Robert, G., Luciano, F., Puissant, A., Gounon, P., Allégra, M., Bertolotto, C., Bereder, J. M., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.86 · Cited by 301 · see citing works

Response of BRAF -Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis

Parmenter, T. J., Kleinschmidt, M., Kinross, K. M., Bond, S. T., Li, J., Kaadige, M. R., Rao, A. D., Sheppard, K. E., Hugo, W., Pupo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0440 · Cited by 281 · see citing works

Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth

Zhao, Y., Zhou, M., Liu, H., Ding, Y., Khong, H. T., Yu, D., Fodstad, Ø., & Tan, M. (2009) · Oncogene · doi:10.1038/onc.2009.229 · Cited by 269 · see citing works

Applying Synthetic Lethality for the Selective Targeting of Cancer

McLornan, D. P., List, A. F., & Mufti, G. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1407390 · Cited by 239 · see citing works

S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma

Deichmann, M., Benner, A., Bock, M., Jäckel, A., Uhl, K., Waldmann, V., & Näher, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1891 · Cited by 231 · see citing works

Metabolic catastrophe as a means to cancer cell death

Jin, S., DiPaola, R. S., Mathew, R., & White, E. (2007) · Journal of Cell Science · doi:10.1242/jcs.03349 · Cited by 229 · see citing works

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

Cerezo, M., Tichet, M., Abbe, P., Ohanna, M., Lehraiki, A., Rouaud, F., Allégra, M., Giacchero, D., Bahadoran, P., Bertolotto, C., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1226-t · Cited by 223 · see citing works

Dichloroacetate induces apoptosis in endometrial cancer cells

Wong, J. Y. Y., Huggins, G. S., Debidda, M., Munshi, N. C., & Vivo, I. D. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.038 · Cited by 220 · see citing works

Phenformin enhances the therapeutic benefit of BRAF V600E inhibition in melanoma

Yuan, P., Ito, K., Pérez‐Lorenzo, R., Guzzo, C. D., Lee, J. H., Shen, C., Bosenberg, M., McMahon, M., Cantley, L. C., & Zheng, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317577110 · Cited by 218 · see citing works

Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response

Sesen, J., Dahan, P., Scotland, S., Saland, E., Dang, V. T., Lemarié, A., Tyler, B., Brem, H., Toulas, C., Moyal, E. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123721 · Cited by 210 · see citing works

Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma

Gopal, Y. N. V., Rizos, H., Chen, G., Deng, W., Frederick, D. T., Cooper, Z. A., Scolyer, R. A., Pupo, G. M., Komurov, K., Sehgal, V., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1392 · Cited by 203 · see citing works

Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene

Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 186 · see citing works

Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells

Filipp, F. V., Scott, D. A., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00989.x · Cited by 181 · see citing works

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

Phoenix, K. N., Vumbaca, F., & Claffey, K. P. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9916-5 · Cited by 173 · see citing works

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP

Lu, M. M., Breyssens, H., Salter, V., Zhong, S., Hu, Y., Baer, C., Ratnayaka, I., Sullivan, A., Brown, N. R., Endicott, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.013 · Cited by 166 · see citing works

The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway

Vijayakumar, M. V., Singh, S., Chhipa, R. R., & Bhat, M. K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706312 · Cited by 163 · see citing works

Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation

Sharma, L. K., Fang, H., Liu, J., Vartak, R. S., Deng, J., & Bai, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr395 · Cited by 157 · see citing works

Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants

Kluza, J., Corazao-Rozas, P., Touil, Y. S., Jendoubi, M., Maire, C., Guerreschi, P., Jonneaux, A., Ballot, C., Balayssac, S., Valable, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0979 · Cited by 152 · see citing works

Synergistic Anti-Cancer Effect of Phenformin and Oxamate

Miskimins, W. K., Ahn, H. J., Kim, J. Y., Ryu, S., Jung, Y., & Choi, J. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085576 · Cited by 144 · see citing works

Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A

Martin, M. J., Hayward, R., Virós, A., & Marais, R. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0280 · Cited by 142 · see citing works

Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin

Dalva-Aydemir, S., Bajpai, R., Martinez, M. S., Adekola, K., Kandela, I. K., Wei, C., Singhal, S., Koblinski, J. E., Raje, N. S., Rosen, S. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1088 · Cited by 141 · see citing works

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

Weide, B., Elsässer, M., Buttner, P. G., Pflugfelder, A., Leiter, U., Eigentler, T., Bauer, J. M., Witte, M. B., Meier, F. E., & Garbe, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.306 · Cited by 141 · see citing works

Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol

Blackman, R. K., Cheung-Ong, K., Gebbia, M., Proia, D. A., He, S., Kepros, J., Jonneaux, A., Marchetti, P., Kluza, J., Rao, P. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029798 · Cited by 132 · see citing works

Metformin is synthetically lethal with glucose withdrawal in cancer cells

Menéndez, J. A., Oliveras‐Ferraros, C., Cufí, S., Corominas-Faja, B., Joven, J., Martı́n-Castillo, B., & Vázquez‐Martín, A. (2012) · Cell Cycle · doi:10.4161/cc.20948 · Cited by 129 · see citing works

Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?

Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 128 · see citing works

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

Avery‐Kiejda, K. A., Bowden, N. A., Croft, A. J., Scurr, L. L., Kairupan, C. F., Ashton, K. A., Talseth‐Palmer, B. A., Rizos, H., Zhang, X. D., Scott, R. J., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-203 · Cited by 113 · see citing works

Lactate Dehydrogenase Isoenzymes 1 and 5: Differential Expression by Neoplastic and Stromal Cells in Non-Small Cell Lung Cancer and Other Epithelial Malignant Tumors

Koukourakis, M. I., Giatromanolaki, A., & Sivridis, E. (2003) · Tumor Biology · doi:10.1159/000074430 · Cited by 108 · see citing works

Mitochondrial Respiration - An Important Therapeutic Target in Melanoma

de Moura, M. B., Vincent, G., Fayewicz, S. L., Bateman, N. W., Hood, B. L., Sun, M., Suhan, J. P., Duensing, S. M., Yin, Y., Sander, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040690 · Cited by 105 · see citing works

Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis

Giatromanolaki, A. N., Sivridis, E., Gatter, K. C., Turley, H., Harris, A. L., & Koukourakis, M. I. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.043 · Cited by 105 · see citing works

Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression

Leontieva, O. V., & Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100402 · Cited by 101 · see citing works

Diet‐induced obesity increases melanoma progression: Involvement of Cav‐1 and FASN

Pandey, V., Vijayakumar, M. V., Ajay, A. K., Malvi, P., & Bhat, M. K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26048 · Cited by 96 · see citing works

Targeting Mitochondrial Oxidative Metabolism in Melanoma Causes Metabolic Compensation through Glucose and Glutamine Utilization

Lim, J.-H., Luo, C., Vazquez, F., & Puigserver, P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2893-t · Cited by 92 · see citing works

Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2‐deoxyglucose and etomoxir

Hernlund, E., Ihrlund, L. S., Khan, O. M., Ateş, Y. Ö., Linder, S. T., Panaretakis, T., & Shoshan, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23525 · Cited by 91 · see citing works

Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells

Calabrese, C., Iommarini, L., Kurelac, I., Calvaruso, M. A., Capristo, M., Lollini, P., Nanni, P., Bergamini, C., Nicoletti, G., Giovanni, C. D., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-11 · Cited by 89 · see citing works

E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells

Wu, M., Seto, E., & Zhang, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3594 · Cited by 87 · see citing works

Suppression of Mitochondrial Complex I Influences Cell Metastatic Properties

He, X., Zhou, A., Lu, H., Chen, Y., Huang, G., Yue, X., Zhao, P., & Wu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061677 · Cited by 71 · see citing works

Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: Role of adipokines

Malvi, P., Chaube, B., Pandey, V., Vijayakumar, M. V., Boreddy, P. R., Mohammad, N., Singh, S. V., & Bhat, M. K. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.006 · Cited by 70 · see citing works

High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene Assays

Houben, R., Hesbacher, S., Schmid, C. P., Kauczok, C. S., Flohr, U., Haferkamp, S., Müller, F. M., Schrama, D., Wischhusen, J., & Becker, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022096 · Cited by 64 · see citing works

Glucose Modulates Respiratory Complex I Activity in Response to Acute Mitochondrial Dysfunction

Cannino, G., El‐Khoury, R., Pirinen, M., Hutz, B., Rustin, P., Jacobs, H. T., & Dufour, É. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386060 · Cited by 59 · see citing works

M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue

Leontieva, O. V., & Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/cc.27973 · Cited by 46 · see citing works

Epidemiology and prevention of cutaneous melanoma

Demierre, M. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0011-z · Cited by 38 · see citing works

Metabolic Approaches to Treatment of Melanoma

Hersey, P., Watts, R. N., Zhang, X. D., & Hackett, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0251 · Cited by 36 · see citing works

Metabolic Flexibility in Health and Disease

Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995 · see citing works

Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease

Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787 · see citing works

Lactate: A Metabolic Driver in the Tumour Landscape

Ippolito, L., Morandi, A., Giannoni, E., & Chiarugi, P. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.10.011 · Cited by 529 · see citing works

Lactate and lactylation in cancer

Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 524 · see citing works

Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications

Fischer, G. M., Gopal, Y. N. V., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 195 · see citing works

The Mitochondrial Complex(I)ty of Cancer

Urra, F. A., Muñoz, F., Lovy, A., & Cárdenas, C. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00118 · Cited by 149 · see citing works

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144 · see citing works

Phenformin as an Anticancer Agent: Challenges and Prospects

Rubiño, M. E. G., Carrillo, E., Ruiz-Alcalá, G., Domínguez‐Martín, A., Marchal, J. A., & Boulaiz, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133316 · Cited by 121 · see citing works

Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes

Allison, K. E., Coomber, B. L., & Bridle, B. W. (2017) · Immunology · doi:10.1111/imm.12777 · Cited by 109 · see citing works

OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles

Zhang, L., Wang, Q., Wang, L., Xie, L., An, Y., Zhang, G., Zhu, W., Li, Y., Liu, Z., Zhang, X., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01262-3 · Cited by 109 · see citing works

Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice

Wang, Z., Guo, J., Han, X., Xue, M., Wang, W., Mi, L., Sheng, Y., Ma, C., Wu, J., & Wu, X. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0332-9 · Cited by 91 · see citing works

Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer

Avolio, R., Matassa, D. S., Criscuolo, D., Landriscina, M., & Esposito, F. (2020) · Biomolecules · doi:10.3390/biom10010135 · Cited by 90 · see citing works

Metabolic Profiles Associated With Metformin Efficacy in Cancer

Andrzejewski, S., Siegel, P. M., & St‐Pierre, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00372 · Cited by 83 · see citing works

Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities

Sarvizadeh, M., Hasanpour, O., Ghale-Noie, Z. N., Mollazadeh, S., Rezaei, M., Pourghadamyari, H., khooy, M. J. M., Aschner, M., Khan, H. Z., Rezaei, N., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650256 · Cited by 81 · see citing works

The Mechanism of Action of Biguanides: New Answers to a Complex Question

Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 75 · see citing works

Valine improves mitochondrial function and protects against oxidative stress

Sharma, S., Zhang, X., Azhar, G., Patyal, P., Verma, A., Grishma, K. C., & Wei, J. Y. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad169 · Cited by 64 · see citing works

Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation

Peppicelli, S., Toti, A., Giannoni, E., Bianchini, F., Margheri, F., Rosso, M. D., & Calorini, L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191706 · Cited by 64 · see citing works

Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells

Li, B., Li, X., Ni, Z., Zhang, Y., Zeng, Y., Yan, X., Huang, Y., He, J., Lyu, X., Wu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10694 · Cited by 55 · see citing works

Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer

Ye, M., Wang, S., Wan, T., Jiang, R., Qiu, Y., Pei, L., Pang, N., Huang, Y., Huang, Y., Zhang, Z., et al. (2017) · Journal of Cancer · doi:10.7150/jca.21035 · Cited by 52 · see citing works

Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer

Montal, E. D., Bhalla, K., Dewi, R. E., Ruiz, C. F., Haley, J. D., Ropell, A. E., Gordon, C. R., Haley, J. D., & Girnun, G. D. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0199-6 · Cited by 50 · see citing works

Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma

Brummer, C., Färber, S., Bruß, C., Blank, C. U., Lacroix, R., Haferkamp, S., Herr, W., Kreutz, M. P., & Renner, K. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.018 · Cited by 48 · see citing works

Metabolic targeting of breast cancer cells with the 2-deoxy-D-glucose and the mitochondrial bioenergetics inhibitor MDIVI-1

Lucantoni, F., Dussmann, H., & Prehn, J. H. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00113 · Cited by 47 · see citing works

IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages

Zhang, J., Yu, D. L., Yu, S. P., Hu, K., Zhang, L., Xiong, M., Liu, M., Sun, X., Li, S., Yuan, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06875-4 · Cited by 46 · see citing works

Flexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment

Bluemel, G., Mondal, A., & Leithner, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031476 · Cited by 44 · see citing works

Mitochondrial Metabolism in Melanoma

Huang, C. Y., Radi, R., & Arbiser, J. L. (2021) · Cells · doi:10.3390/cells10113197 · Cited by 40 · see citing works

Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review

Kiran, D., & Basaraba, R. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.624607 · Cited by 39 · see citing works

Combination of Metformin, Sodium Oxamate and Doxorubicin Induces Apoptosis and Autophagy in Colorectal Cancer Cells via Downregulation HIF-1α

Coronel-Hernández, J., Salgado-García, R., de León, D. F. C., Jacobo-Herrera, N. J., Millán-Catalán, O., Delgado-Waldo, I., Campos-Parra, A. D., Rodríguez-Morales, M., Delgado‐Buenrostro, N. L., & Pérez‐Plasencia, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.594200 · Cited by 40 · see citing works

Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification

Chen, W., Liu, J., Zheng, C., Bai, Q., Gao, Q., Zhang, Y., Dong, K., & Lu, T. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s366187 · Cited by 39 · see citing works

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma

Feng, Y., Pathria, G., Heynen‐Genel, S., Jackson, M., James, B. P., Yin, J., Scott, D. A., & Ronai, Z. A. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0354 · Cited by 35 · see citing works

Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter

Singh, S. V., Chaube, B., Mayengbam, S. S., Singh, A., Malvi, P., Mohammad, N., Deb, A., & Bhat, M. K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166011 · Cited by 33 · see citing works

Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies

Alkaraki, A., McArthur, G. A., Sheppard, K. E., & Smith, L. K. (2021) · Cancers · doi:10.3390/cancers13225810 · Cited by 32 · see citing works

Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly

Iversen, A. B. B., Horsman, M. R., Jakobsen, S., Jensen, J., Garm, C., Jessen, N., Breining, P., Frøkiær, J., & Busk, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10010-z · Cited by 28 · see citing works

Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells

Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00315-1 · Cited by 28 · see citing works

Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts

Koltai, T., & Fliegel, L. (2024) · Pharmaceuticals · doi:10.3390/ph17060744 · Cited by 28 · see citing works

Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma

Gerthofer, V., Kreutz, M. P., Renner, K., Jachnik, B., Dettmer, K., Oefner, P. J., Riemenschneider, M. J., Proescholdt, M. A., Vollmann‐Zwerenz, A., Hau, P., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092586 · Cited by 27 · see citing works

Diabetes and Cancer: A Twisted Bond

Stan, M. C., & Paul, D. (2024) · Oncology Reviews · doi:10.3389/or.2024.1354549 · Cited by 26 · see citing works

Metformin Treatment or PRODH/POX-Knock out Similarly Induces Apoptosis by Reprograming of Amino Acid Metabolism, TCA, Urea Cycle and Pentose Phosphate Pathway in MCF-7 Breast Cancer Cells

Huynh, T. Y. L., Ościłowska, I., Sáiz, J., Nizioł, M., Baszanowska, W., Barbas, C., & Palka, J. A. (2021) · Biomolecules · doi:10.3390/biom11121888 · Cited by 23 · see citing works

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

Zhang, L., Han, J., Jackson, A. L., Clark, L., Kilgore, J., Guo, H., Livingston, N., Batchelor, K. W., Yin, Y., Gilliam, T. P., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0325-7 · Cited by 22 · see citing works

Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect

Zhang, X., Tai, Z., Miao, F., Huang, H., Zhu, Q., Bao, L., & Chen, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1046102 · Cited by 22 · see citing works

Suppression of tumor growth and metastasis by ethanol extract of Angelica dahurica Radix in murine melanoma B16F10 cells

Hwangbo, H., Choi, E. O., Kim, M. Y., Kwon, D. H., Ji, S. Y., Lee, H., Hong, S. H., Kim, G., Hwang, H. J., Hong, S. H., et al. (2020) · BioScience Trends · doi:10.5582/bst.2019.01230 · Cited by 21 · see citing works

Proline Dehydrogenase/Proline Oxidase (PRODH/POX) Is Involved in the Mechanism of Metformin-Induced Apoptosis in C32 Melanoma Cell Line

Ościłowska, I., Rolkowski, K., Baszanowska, W., Huynh, T. Y. L., Lewoniewska, S., Nizioł, M., Sawicka, M., Bielawska, K., Szoka, P., Miltyk, W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042354 · Cited by 21 · see citing works

Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model

Wu, Z., Liu, W. Y., Wang, Z., Zeng, B., Peng, G., Niu, H., Chen, L., Liu, C., Hu, Q., Zhang, Y., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1112-7 · Cited by 20 · see citing works

Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications

Wu, P., Zhang, J., Jiang, Z., Liu, X., Jiang, N., Zou, J., Chen, X., Wu, D., & Li, Y. (2026) · Biomarker Research · doi:10.1186/s40364-026-00898-z · Cited by 20 · see citing works

Downregulation of respiratory complex I mediates major signalling changes triggered by TOR activation

Pérez-Gómez, R., Magnin, V., Mihajlović, Z., Slaninová, V., & Krejčı́, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-61244-3 · Cited by 19 · see citing works

Citrus unshiu peel suppress the metastatic potential of murine melanoma B16F10 cells in vitro and in vivo

Choi, E. O., Lee, H., Hwangbo, H., Kwon, D. H., Kim, M. Y., Ji, S. Y., Hong, S. H., Kim, G., Park, C., Hwang, H., et al. (2019) · Phytotherapy Research · doi:10.1002/ptr.6497 · Cited by 17 · see citing works

Kinetic modeling of glucose central metabolism in hepatocytes and hepatoma cells

Marín‐Hernández, Á., Gallardo‐Pérez, J. C., Reyes‐García, M. A., Sosa‐Garrocho, M., Macías‐Silva, M., Rodríguez‐Enríquez, S., Moreno‐Sánchez, R., & Saavedra, E. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129687 · Cited by 17 · see citing works

Mitochondrial division inhibitor (mdivi-1) induces extracellular matrix (ECM)-detachment of viable breast cancer cells by a DRP1-independent mechanism

Silva-Pavez, E., Mendoza, E., Morgado-Cáceres, P., Ahumada-Castro, U., Bustos, G., Kangme-Encalada, M., de Arbina, A. L., Puebla-Huerta, A., Muñoz, F., Cereceda, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-64228-9 · Cited by 15 · see citing works

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ

Wang, L., Yang, X., Li, D., Liang, Z., Chen, Y., Ma, G., Wang, Y., Li, Y., Liang, Y., & Niu, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s180505 · Cited by 14 · see citing works

Metformin: oxidative and proliferative parameters in-vitro and in-vivo models of murine melanoma

Neto, F. P. D. S., Bernardes, S. S., Marinello, P. C., Melo, G. P., Luiz, R. C., Cecchini, R., & Cecchini, A. L. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000391 · Cited by 14 · see citing works

Gboxin Induced Apoptosis and Ferroptosis of Cervical Cancer Cells by Promoting Autophagy-Mediated Inhibition of Nrf2 Signaling Under Low-Glucose Conditions

Liu, W., Lu, J., Li, J., Wang, L., Chen, Y., Wu, Y., Zhang, Z., Zhang, J., Gao, F., Jia, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020502 · Cited by 12 · see citing works

ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations

Moral‐Sanz, J., Fernandez-Rojo, M. A., Potriquet, J., Mukhopadhyay, P., Brust, A., Wilhelm, P., Smallwood, T. B., Clark, R. J., Fry, B. G., Alewood, P. F., et al. (2021) · Toxins · doi:10.3390/toxins13020146 · Cited by 11 · see citing works

The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells

Singh, S. V., Carlo, F. D., Ibrahim, M. A., Penfornis, P., Mouton, A. J., Tripathi, S., Agarwal, A. K., Eastham, L. L., Pasco, D. S., Balachandran, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097741 · Cited by 11 · see citing works

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines

Delgado-Waldo, I., Contreras-Romero, C., Salazar-Aguilar, S., Pessoa, J., Mitre-Aguilar, I. B., García-Castillo, V., Pérez‐Plasencia, C., & Jacobo-Herrera, N. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1106667 · Cited by 10 · see citing works

A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression

Zhang, J., Ye, Z., Bräutigam, L., Chakraborty, P., Luo, Z., Culpepper, J., Aslam, M., Zhang, L., Johansson, K., Haeggström, J. Z., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104920 · Cited by 10 · see citing works

Lactate metabolism and protein lactylation in cancer

Liu, Z., Li, A., Ma, Z., Wang, J., Chen, X., Wang, Z., & Fu, R. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00417-4 · Cited by 9 · see citing works

ATP Supply from Cytosol to Mitochondria Is an Additional Role of Aerobic Glycolysis to Prevent Programmed Cell Death by Maintenance of Mitochondrial Membrane Potential

Sawai, A., Taniguchi, T., Noguchi, K., Seike, T., Okahashi, N., Takaine, M., & Matsuda, F. (2025) · Metabolites · doi:10.3390/metabo15070461 · Cited by 7 · see citing works

Antiproliferative effects of LY-2183240 combined with various chemotherapeutic drugs in an isobolographic in vitro model of malignant melanoma

Marzęda, P., Wróblewska-Łuczka, P., Florek-Łuszczki, M., Góralczyk, A., & Łuszczki, J. J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176937 · Cited by 7 · see citing works

Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria

Wu, T., Zhou, S., Qin, M., Tang, J. Y., Yan, X., Huang, L., Huang, M., Deng, J., Xiao, D., Hu, X., et al. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13152 · Cited by 7 · see citing works

Lactylation in cancer: Advances and opportunities for treatment resistance

Xu, K., Shou, Y., Liu, R., Xiong, H., Dai, X., Bao, X., Chen, X., Huang, L., Sheng, H., Zhang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70478 · Cited by 6 · see citing works

Enhancement of Acetate-Induced Apoptosis of Colorectal Cancer Cells by Cathepsin D Inhibition Depends on Oligomycin A-Sensitive Respiration

Alves, S., Santos‐Pereira, C., Oliveira, C. S., Preto, A., Chaves, S. R., & Côrte‐Real, M. (2024) · Biomolecules · doi:10.3390/biom14040473 · Cited by 6 · see citing works

Is age-related failure of metabolic reprogramming a principal mediator in idiopathic Parkinson’s disease? Implications for treatment and inverse cancer risk

Engel, P. A. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.05.033 · Cited by 6 · see citing works

Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells

Shen, H. M., Huynh, Q.-S., Mudassar, F., Chang, C., Gloss, B., Ing, P., Ma, S., Gee, H. E., Hau, E. K. C., & Cook, K. M. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00411-4 · Cited by 3 · see citing works

Anti-tumor response by targeting glucose metabolism and depletion of membrane cholesterol in breast cancer and melanoma cells

Yaduvanshi, H., Deshmukh, B., Singh, A., Mayengbam, S. S., & Bhat, M. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120088 · Cited by 3 · see citing works

Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma

Lin, W., Tan, Z.-Y., & Fang, X.-C. (2023) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2023.08.001 · Cited by 3 · see citing works

Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation

Zhang, D., He, Y., & He, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117499 · Cited by 2 · see citing works

The Pivotal Role of Senescence in Cell Death and Aging: Where Do We Stand?

Sadaf, S., Najm, M. Z., Shingatgeri, V., Uddin, M., Izhari, M. A., Akhtar, S., Kathait, A., Kar, S., Jain, I., Datt, P., et al. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00129-w · Cited by 1 · see citing works

Repositioning of Metformin: Anticancer Agent for Hypoxic Neuroblastoma Cells

Surer, S. I., Toksöz, F., Bayrak, S., Meco, H. E., Sever, T., Başbınar, Y., & Olgun, H. N. (2020) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.2020.1373 · Cited by 1 · see citing works

Pharmacological interventions part IV: Metabolic modifiers

Koltai, T., Reshkin, S. J., & Harguindey, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819059-3.00016-2 · Cited by 1 · see citing works

Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers

Pandiaraja, J. (2019) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_204_18

A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells

Grahovac, J., Pavlović, M., & Ostojić, M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1205-7_5

Determinación de la vía de apoptosis inducida en cáncer cervicouterino a través de la combinación farmacológica de metformina, oxamato de sodio y doxorrubicina en un modelo in vitro

Waldo, R. I. D. (2020) · doi:10.24275/uami.sn009x805

Enolase inhibition reduces autophagy and promotes neurological function recovery after spinal cord injuryPreprint

Zhou, Z., Wu, J., Yang, X., Pan, W., Li, X., & Zhang, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-2259585/v1

Molecular Mechanisms of Anticarcinogenic Potential of Hydrocotyle umbellata and Its Major Components

Kim, J.-K., Park, S. H., Kim, D.-Y., Ryu, H. W., & Jun, H. S. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2377344

Conserved metabolic adaptation mechanisms in cancer cells and yeast against mitochondrial dysfunction indicate an additional role of aerobic glycolysis for cell survivalPreprint

Sawai, A., Taniguchi, T., Noguchi, K., Seike, T., Okahashi, N., Takaine, M., & Matsuda, F. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.16.637991

Metformin-Induced Mitochondrial Remodeling Creates Adaptive and Targetable Vulnerabilities in Cancer CellsPreprint

Bhati, F. K., Saha, U., Singh, S., & Bhat, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656565

Additional file 2 of Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells

Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023) · Figshare · doi:10.6084/m9.figshare.24136373

Additional file 1 of Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells

Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023) · Figshare · doi:10.6084/m9.figshare.24136370

Lactate and lysine lactylation: Emerging drivers shaping tumor immune evasion

Fan, S., Lu, S., Peng, Z., Mao, G., Wu, Z., Song, T., Cai, M., Gao, Y., Li, X. B., Li, C., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117130

A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells

Grahovac, J., Pavlović, M., Živić, K., & Ostojić, M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5619-8_4

Abstract 1384: Mitochondrial complex I inhibition enhances chemotherapy efficacy in melanoma

Ali, S. A., Zarei, M., Rothermel, L. D., & Winter, J. M. (2025) · Cancer Research · doi:10.1158/1538-7445.am2025-1384

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

AbuEid, M., McAllister, D. M., McOlash, L., Harwig, M. C., Cheng, G., Drouillard, D., Boyle, K. A., Hardy, M., Zielonka, J., Johnson, B. D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102653 · Cited by 28 · see citing works

Additional file 2: Figure S2. of Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth

Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H. H., Erdmann, G., Algire, C., Hägebarth, A., Peter, W., Kopitz, C., et al. (2015) · Figshare · doi:10.6084/m9.figshare.10035170

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis

Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105 · see citing works

Additional file 4: Figure S4. of Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth

Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H. H., Erdmann, G., Algire, C., Hägebarth, A., Peter, W., Kopitz, C., et al. (2015) · Figshare · doi:10.6084/m9.figshare.10035179